Emily Leproust

Emily Leproust

DirectoratTwist Bioscience· In proxies 2021–2025

Pay in FY2025+81% from the year before · Twist Bioscience stock -37.7% the same year

Emily Leproust was paid $13.8M in FY2025 (Sep), up 81%. Twist Bioscience stock fell 37.7% that year.

Pay$100 in the stock at the end of FY20 → $37
Pay is from the Summary Compensation Table of each Twist Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. GeneDx HoldingsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Twist BiosciencePublic company · 5 yr
    • Ph.D. Chief Executive Officer and Chair of the Board2021 – Present · 5 yrStock in role +168%
  3. Sema4 Holdings Corp.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • GeneDx HoldingsDirector · 5 yr on the boardIndependentAudit, Compensation, Nominating and Corporate Governance (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?